Cargando…
Is there evidence of placental hypoperfusion in SARS-CoV-2 positive patients?
Autores principales: | Buckley, Ayisha B., Hyman, Katelynn, Khandakar, Binny, Ahuja, Sadhna, Roig, Jacqueline, DeBolt, Chelsea A., Cabrera, Camila, Cochrane, Elizabeth, Stone, Joanne, Dekio, Fumiko, Bianco, Angela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Mosby, Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8696635/ http://dx.doi.org/10.1016/j.ajog.2021.11.1240 |
Ejemplares similares
-
140 SARS-CoV 2 antibody response among women infected during pregnancy at Mount sinai hospital
por: Buckley, Ayisha B., et al.
Publicado: (2021) -
Evaluation of inflammatory responses to COVID-19 mRNA vaccines in human placental explants
por: Gonzalez, Veronica, et al.
Publicado: (2023) -
A descriptive comparison of placental pathology in Covid-19 patients with and without hypertensive disease (HTND)
por: Nittur, Nandini R., et al.
Publicado: (2022) -
Increased prevalence of high grade placental pathology with first trimester SARS-CoV-2 infection
por: Suresh, Sunitha C., et al.
Publicado: (2022) -
Placental histopathologic findings from pregnancies diagnosed with COVID-19: A systematic review and meta-analysis
por: Hessami, Kamran, et al.
Publicado: (2022)